Abiopharma

🔍 ROTHBLATT MARTINE A (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Acquired 9,500 shares of Common Stock at $135.42 per share (Direct)
  Date: 2026-08-19 | Code: M | equity_swap_involved: false | shares_owned_after: 333,943.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 240 shares of Common Stock at $522.4866 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 333,703.00 | transaction_form_type: 4 | Footnotes: F1, F3, F2
• Sold 1,264 shares of Common Stock at $523.6459 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 332,439.00 | transaction_form_type: 4 | Footnotes: F1, F4, F2
• Sold 441 shares of Common Stock at $524.5108 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 331,998.00 | transaction_form_type: 4 | Footnotes: F1, F5, F2
• Sold 895 shares of Common Stock at $525.5962 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 331,103.00 | transaction_form_type: 4 | Footnotes: F1, F6, F2
• Sold 2,105 shares of Common Stock at $526.7632 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 328,998.00 | transaction_form_type: 4 | Footnotes: F1, F7, F2
• Sold 2,135 shares of Common Stock at $527.5763 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 326,863.00 | transaction_form_type: 4 | Footnotes: F1, F8, F2
• Sold 1,200 shares of Common Stock at $528.5872 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 325,663.00 | transaction_form_type: 4 | Footnotes: F1, F9, F2
• Sold 659 shares of Common Stock at $529.5583 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 325,004.00 | transaction_form_type: 4 | Footnotes: F1, F10, F2
• Sold 201 shares of Common Stock at $531.006 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 324,803.00 | transaction_form_type: 4 | Footnotes: F1, F11, F2
• Sold 80 shares of Common Stock at $531.6223 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 324,723.00 | transaction_form_type: 4 | Footnotes: F1, F12, F2
• Sold 200 shares of Common Stock at $532.63 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 324,523.00 | transaction_form_type: 4 | Footnotes: F1, F13, F2
• Sold 80 shares of Common Stock at $535.215 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 324,443.00 | transaction_form_type: 4 | Footnotes: F1, F14, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-19 | Code: H | shares_owned_after: 40,513.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-19 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 166.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-19 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 249,108.00 | Footnotes: F15
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-19 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 45,596.00 | Footnotes: F16
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-19 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 8,902.00 | Footnotes: F17
• Sold 9,500 shares of Stock Option at $135.42 per share (Derivative)
  Date: 2026-08-19 | Code: M | Expires: 2027-03-15 | Exercise: 2023-03-15 | equity_swap_involved: false | shares_owned_after: 103,910.00 | transaction_form_type: 4 | Footnotes: F1, F18

Footnotes:

• F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
• F10: This transaction was executed in multiple trades at prices ranging from $529.24 to $530.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F11: This transaction was executed in multiple trades at prices ranging from $530.27 to $531.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F12: This transaction was executed in multiple trades at prices ranging from $531.49 to $531.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F13: This transaction was executed in multiple trades at prices ranging from $532.53 to $532.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F14: This transaction was executed in multiple trades at prices ranging from $535.20 to $535.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F15: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F16: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F17: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F18: Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
• F2: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F3: This transaction was executed in multiple trades at prices ranging from $522.04 to $522.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $523.08 to $524.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $524.10 to $525.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $525.12 to $526.115. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $526.14 to $527.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $527.14 to $528.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $528.17 to $528.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.